Australia Markets closed

Surgalign Holdings, Inc. (SRGA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.6000-0.0500 (-3.03%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.74
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 39.0000
52-week low 31.3400
50-day moving average 31.9458
200-day moving average 32.8215

Share statistics

Avg vol (3-month) 359.69k
Avg vol (10-day) 343.14k
Shares outstanding 512.76M
Implied shares outstanding 6N/A
Float 86.11M
% held by insiders 121.58%
% held by institutions 114.48%
Shares short (12 Jan 2023) 4110.57k
Short ratio (12 Jan 2023) 41.23
Short % of float (12 Jan 2023) 40.91%
Short % of shares outstanding (12 Jan 2023) 40.87%
Shares short (prior month 14 Dec 2022) 4102.93k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -73.11%
Operating margin (ttm)-65.53%

Management effectiveness

Return on assets (ttm)-27.85%
Return on equity (ttm)-350.69%

Income statement

Revenue (ttm)83.24M
Revenue per share (ttm)14.05
Quarterly revenue growth (yoy)-1.80%
Gross profit (ttm)62.76M
EBITDA -52.19M
Net income avi to common (ttm)-62.42M
Diluted EPS (ttm)-1.2950
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.85M
Total cash per share (mrq)2.05
Total debt (mrq)11.16M
Total debt/equity (mrq)90.19
Current ratio (mrq)1.92
Book value per share (mrq)0.34

Cash flow statement

Operating cash flow (ttm)-55.97M
Levered free cash flow (ttm)-41.47M